PHARMACOECONOMIC JUSTIFICATION OF A WIDER USE OF PREVENTIVE HEMOPHILIA THERAPY IN THE RUSSIAN FEDERATION
The aim – assess the clinical advantages and economic burden of various treatment strategies in patients with hemophilia A in the Russian Federation and propose the ways of optimizing this area of medical care.Materials and methods. A mathematical model describing the current (2017) approach to ther...
| Hlavní autoři: | , |
|---|---|
| Médium: | Článek |
| Jazyk: | Russian |
| Vydáno: |
IRBIS LLC
2018-02-01
|
| Edice: | Фармакоэкономика |
| Témata: | |
| On-line přístup: | https://www.pharmacoeconomics.ru/jour/article/view/212 |